reference/21356379

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21356379

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase I\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	3276
issn	1527-7755 0732-183X
issueIdentifier	16
pageRange	3269-3276
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	3269
bibliographicCitation	Schey SA, Fields P, Bartlett JB, Clarke IA, Ashan G, Knight RD, Streetly M, Dalgleish AG. Phase I study of an immunomodulatory thalidomide analog, CC-4047, in relapsed or refractory multiple myeloma. J Clin Oncol. 2004 Aug 15;22(16):3269–76. doi: 10.1200/jco.2004.10.052. PMID: 15249589.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_77c113a1fd46846b247a8d9f627444e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f209d5a866123081e7e22c3831f235cc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b598e0456ef7641d4876a1c424ab40fb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_17e48c9bb2c1c153ef7bc8c1a5cdf831 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3373fd15fd56c346cdc1fce197219e1e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3d74f52411ae4fc801b0c7f39d4adcf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b2fece0e9b455f2f12501a854be199f9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20147eb9fc2f99f7c4ec42223c9a9ef2
date	2004-08-15^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1200/jco.2004.10.052 https://pubmed.ncbi.nlm.nih.gov/15249589
isPartOf	https://portal.issn.org/resource/ISSN/0732-183X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/1527-7755
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Phase I Study of an Immunomodulatory Thalidomide Analog, CC-4047, in Relapsed or Refractory Multiple Myeloma
discusses	http://id.nlm.nih.gov/mesh/M0021267 http://id.nlm.nih.gov/mesh/M0024747 http://id.nlm.nih.gov/mesh/M0441603
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D013792Q000494 http://id.nlm.nih.gov/mesh/D013792Q000031 http://id.nlm.nih.gov/mesh/D009101Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D016207Q000097 http://id.nlm.nih.gov/mesh/D012008 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D013792Q000009 http://id.nlm.nih.gov/mesh/D009101Q000473 http://id.nlm.nih.gov/mesh/D013792Q000008 http://id.nlm.nih.gov/mesh/D020714 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_29f84c0d894769b14b36c5f43f54153e http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8561 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8530 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6590 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8448 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134780 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_68000b5f90a1d5b5b1a93dbb8aa92d3e http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5426 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8661 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10516

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129356432 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129427475

Showing number of triples: 1 to 58 of 58.